StockNews.com started coverage on shares of Organovo (NASDAQ:ONVO – Free Report) in a research note released on Saturday morning. The firm issued a sell rating on the medical research company’s stock.
Organovo Stock Performance
Shares of NASDAQ ONVO opened at $0.68 on Friday. Organovo has a 12-month low of $0.64 and a 12-month high of $2.05. The firm has a market capitalization of $9.74 million, a price-to-earnings ratio of -0.42 and a beta of 0.68. The firm has a 50 day moving average of $0.90 and a 200 day moving average of $0.99.
About Organovo
See Also
- Five stocks we like better than Organovo
- How to Evaluate a Stock Before BuyingÂ
- Automaker’s Bold Move to an EV Future: Is It Time to Buy Stock?
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Massive Breakout: This ETF Signals Big Gains for Small-Cap Stocks
- How to Capture the Benefits of Dividend Increases
- Major Gaming Stock to Watch: Why It’s a Safe Bet Now
Receive News & Ratings for Organovo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organovo and related companies with MarketBeat.com's FREE daily email newsletter.